Table 6.
Anti-rejection therapy | n (52) |
---|---|
CS + ATG + IVIg + R+PP + E | 1 |
CS + IVIg + R+PP + E+A | 1 |
CS + ATG + IVIg + R+PP | 1 |
CS | 2 |
CS + ATG | 2 |
CS + ATG + IVIg | 2 |
CS + ATG + R+PP | 3 |
CS + R+PP | 4 |
CS + IVIg + R+PP | 5 |
CS + ATG + IVIg + PP | 5 |
CS + ATG + PP | 7 |
CS + IVIg + PP | 8 |
CS + PP | 11 |
A: alemtuzumab; ATG: anti-thymocyte globulin; E: eculizimab; IVIg: intravenoz immunoglobulin; CS: corticosteroid pulse; PP: plasmapheresis; R: rituximab.